USFDA10 Apr 2024, 09:31 pm
Dr. Reddy's Laboratories Launches Drug-Free Migraine Management Device Nerivio® in Europe
AI Summary
Dr. Reddy's Laboratories has launched the drug-free, non-invasive migraine management wearable device Nerivio® in Europe. Approved by the USFDA and CE-mark certified, Nerivio® uses Remote Electrical Neuromodulation (REN) technology for acute and preventive migraine treatment. The device, which has benefited over 45,000 patients globally, will be presented at various European neurology conferences. Dr. Reddy's will introduce Nerivio® in South Africa this month, followed by launches in Spain and the UK.
Key Highlights
- Dr. Reddy's launches Nerivio®, a drug-free migraine management device, in Europe.
- Nerivio® is USFDA-approved and CE-mark certified.
- The device uses Remote Electrical Neuromodulation (REN) technology for migraine treatment.
- Over 45,000 patients have benefited from Nerivio® globally.
- Dr. Reddy's will present and launch Nerivio® at various European neurology conferences.